更新于：2024-11-01

Western Galilee Hospital

更新于：2024-11-01

概览

概览

关联

项与 Western Galilee Hospital 相关的临床试验

NCT06578754 / Not yet recruitingN/AIIT

Validation Test for Plasma Oxalate Level in a Biochemical Laboratory at the Galilee Medical Center

Given the need to perform an oxalate plasma test in Israel, and being a leading center in the field of hyperoxaluria in Israel, the investigators are interested in placing the test in the biochemical laboratory at our institution but require validation levels in comparison with leading laboratory in Europe.

开始日期2024-09-01

申办/合作机构

Western Galilee Hospital

NCT06547437 / Not yet recruitingN/AIIT

"Evaluating the Effectiveness of Papaverine as an Adjunct to Oxytocin for Labor Induction: A Randomized Controlled Trial"

This study aims to evaluate the efficacy and safety of combining papaverine with oxytocin for labor induction compared to oxytocin alone

开始日期2024-09-01

申办/合作机构

Western Galilee Hospital

NCT06550232 / Not yet recruiting临床4期IIT

The Effect of IV PAPAVERINE 80 mg Prior to Propess on Bishop Score and Pain, Double Blinded Randomized Placebo Controlled Trial

We aim to evaluate the effect of administering papaverine prior to PGE2 (propess) insertion on changes in Bishop-scores and on the induction-to-delivery interval.

开始日期2024-08-11

申办/合作机构

Western Galilee Hospital

100 项与 Western Galilee Hospital 相关的临床结果

登录后查看更多信息

0 项与 Western Galilee Hospital 相关的专利（医药）

登录后查看更多信息

638

项与 Western Galilee Hospital 相关的文献（医药）

2021-12-06·Leukemia & Lymphoma4区 · 医学

COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome

4区 · 医学

Article

作者: Sherf, Yehonatan ; Jarchowsky, Osnat ; Leiba, Merav ; Lavi, Avital ; Berger, Tamar ; Harel, Reut ; Zimran, Eran ; Aumann, Shlomzion ; Raanani, Pia ; Itchaki, Gilad ; Sofer, Orit ; Sarid, Nadav ; Mittelman, Moshe ; Suriu, Celia ; Aviv, Ariel ; Lavi, Noa ; Tadmor, Tamar ; Halloun, Jabour ; Ben Barouch, Sharon ; Braester, Andrei ; Levy, Ilana ; Grisariu, Sigal ; Shpilberg, Ofer ; Koren-Michowitz, Maya ; Shvidel, Lev ; Herzog Tzarfati, Katrin ; Goldstein, Daniela ; Dally, Nagib ; Yeganeh, Shay ; Zuckerman, Tsila ; Ellis, Martin ; Levi, Itai

This national Israeli multicenter retrospective study aimed to characterize the clinical course of COVID-19 infection among patients with hematological malignancies, with special emphasis on treatment efficacy and outcome. Clinical and laboratory data from haemato-oncological patients diagnosed with COVID-19 from 16 medical centers were centrally reported. Multivariate regression analyses were used to determine variables associated with severe disease, hospitalization, and mortality. In total, 313 patients were included: 103 (35.7%) developed severe/critical respiratory infection, 178 (61.4%) were hospitalized, and 60 (20.0%) died. Age > 70 years was associated with severe/critical disease (p = 0.036) and mortality (p = 0.023), hypertension with severe/critical disease (p = 0.046) and hospitalization (p = 0.001), active haemato-oncological treatment with hospitalization (p = 0.009), and remdesivir treatment was associated with decreased mortality (p = 0.021). Convalescent plasma, enoxaparin, and corticosteroids resulted in no clinical benefit. In conclusion, COVID-19 infection seems particularly severe in patients with hematological malignancies, and of all examined therapies, remdesivir appears to be the most effective.

2021-10-12·European Heart Journal

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in Israel

作者: Efraim, R ; Fardman, A ; Henri Fortis, L ; Matetzky, S ; Tsafrir, O ; Mohsen, M ; Asher, E ; Zahger, D ; Kofman, N ; Rubinshtein, R ; Jamal, J ; Halabi, M ; Beigel, R ; Shacham, Y ; Orvin, K

AbstractBackgroundSince the COVID-19 pandemic outbreak several countries have reported a decrease in the number of patients admitted with non-ST elevation myocardial infarction (NSTEMI).PurposeWe aimed to evaluate admission trend and outcomes of patients with NSTEMI in the COVID-19 era in a nationwide survey.MethodsA prospective, multicenter, observational, nationwide study involving 13 medical centers across Israel. All NSTEMI patients admitted to intensive cardiac care units (ICCUs) over an 8-week period during the COVID-19 outbreak were compare them with NSTEMI patients admitted 2 years earlier (control period) during the Acute Coronary Syndrome Israeli Survey (ACSIS) 2018.ResultsThere were 624 (43%) NSTEMI patients, of them 349 (56%) hospitalized during the COVID-19 era and 275 (44%) during the control period, representing a 27% increase in NSTEMI admission rate during the COVID-19 era. Approximately 76% were male, median age was 67 years (IQR 58–76). There were no differences in baseline characteristics between the two study periods. During the COVID-19 era, more patients arrived at the hospital via an emergency medical system (EMS) compared with the control period (p for trend = 0.005)Time from symptom onset to hospital admission was longer in the COVID-19 era [687.00 (IQR147–2805) vs. 178.00 (IQR 102- 407), respectively, p-value <0.001]. Nevertheless, time from hospital admission to reperfusion was similar in both groups. Rate of percutaneous coronary intervention was higher in the COVID-19 era group (91.3% vs. 59.7%, respectively, p<0.001). In-hospital mortality rate was similar in both groups (2.3% vs. 4.7%, respectively, p=0.149) as was the 30-day mortality rate (3.7% vs. 5.1%, respectively, p=0.238).ConclusionsIn contrast to previous reports, in Israel, admission rate of NSTEMI was increased during the COVID-19 era. With longer time from symptoms to admission, but with the same time from hospital admission to reperfusion therapy and with similar in-hospital and 30-day mortality rates.Funding AcknowledgementType of funding sources: None.

2021-05-01·The Israel Medical Association journal : IMAJ4区 · 医学

Treatment of Peripheral Nerve Injuries in Syria's War Victims: Experience from a Northern Israeli Hospital.

4区 · 医学

Article

作者: Iordache, Sorin Daniel ; Nahas, Marwa ; Rahamimov, Nimrod ; Frenkel Rutenberg, Tal ; Feintuch, Lior ; Gorski, Albert

BACKGROUNDThe collapse of the Syrian healthcare system during the civil war led numerous citizens to cross the Syrian-Israeli border to seek medical care.OBJECTIVESTo describe the epidemiology of peripheral nerve injuries (PNIs) sustained in war, their management, and short-term outcomes.METHODSA retrospective case series study was conducted on 45 consecutive patients aged 25.7 ± 9.3 years. These patients were referred to the hand surgery unit of the department of orthopedic surgery and traumatology at Galilee Medical Center between December 2014 and June 2018. Median time between injury and presentation was 60 days. Injury pattern, additional injuries, surgical findings and management, complications, and length of hospital stay were extracted from medical records.RESULTSMost injuries were blast (55.6%) followed by gunshot injuries (37.8%). There were 9 brachial plexus injuries, 9 sciatic nerve injuries, and 38 PNIs distal to the plexus: specifically 20 ulnar, 11 median, and 7 radial nerve injuries. In the latter group, neurotmesis or axonotmesis was found in 29 nerves. Coaptation was possible in 21 nerves necessitating cable grafting in 19. A tendon transfer was performed for 13 peripheral nerves, occasionally supplementing the nerve repair. The patients returned to their country after discharge, average follow-up was 53.6 ± 49.6 days.CONCLUSIONSFor nerve injuries sustained in war, early surgical treatment and providing adequate soft tissue conditions is recommended. Tendon transfers are useful to regain early function.

100 项与 Western Galilee Hospital 相关的药物交易

登录后查看更多信息

100 项与 Western Galilee Hospital 相关的转化医学

登录后查看更多信息